RecruitingEarly Phase 1NCT06650319

A Clinical Study to Evaluate the Safety and Efficacy of LY-M003 Injection in Patients With Wilson Disease

Studying Wilson disease

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Chaohui Yu
Principal Investigator
Chaohui Yu, PhD
First Affiliated Hospital of Zhejiang University
Intervention
LY-M003(genetic)
Enrollment
18 enrolled
Eligibility
10-60 years · All sexes
Timeline
20242026

Study locations (1)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT06650319 on ClinicalTrials.gov

Other trials for Wilson disease

Additional recruiting or active studies for the same condition.

See all trials for Wilson disease

← Back to all trials